USANA Health Sciences (NYSE:USNA) Posts Earnings Results

USANA Health Sciences (NYSE:USNA) announced its quarterly earnings results on Tuesday. The company reported $0.56 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.07, Yahoo Finance reports. USANA Health Sciences had a return on equity of 11.13% and a net margin of 6.29%. The company had revenue of $200.22 million during the quarter, compared to analysts’ expectations of $208.45 million. During the same quarter in the previous year, the firm earned $0.59 earnings per share. USANA Health Sciences updated its FY 2024 guidance to 2.450-2.450 EPS.

USANA Health Sciences Price Performance

Shares of USNA stock traded up $1.26 during trading hours on Wednesday, reaching $35.74. The company had a trading volume of 19,433 shares, compared to its average volume of 79,629. The firm has a market cap of $680.88 million, a price-to-earnings ratio of 10.55, a P/E/G ratio of 1.20 and a beta of 0.89. USANA Health Sciences has a 1-year low of $34.15 and a 1-year high of $55.45. The company has a 50 day moving average of $38.02 and a 200 day moving average of $42.59.

Analyst Ratings Changes

USNA has been the topic of several analyst reports. StockNews.com lowered USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 24th. DA Davidson decreased their price target on USANA Health Sciences from $38.00 to $35.00 and set a “neutral” rating on the stock in a research report on Wednesday.

Insider Buying and Selling

In other USANA Health Sciences news, Director Gilbert A. Fuller sold 674 shares of the stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $39.69, for a total transaction of $26,751.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, insider Paul A. Jones sold 6,266 shares of USANA Health Sciences stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $38.38, for a total value of $240,489.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Gilbert A. Fuller sold 674 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $39.69, for a total transaction of $26,751.06. The disclosure for this sale can be found here. In the last quarter, insiders have sold 7,940 shares of company stock valued at $311,670. 0.33% of the stock is owned by company insiders.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.